Dashboard
Manage Tickers

OACBOaktree Acquisition Corp. II

NYSE www.oaktreeacquisitioncorp.com


$ 9.41 $ -0.11 (-1.16 %)    

Wednesday, 15-Jun-2022 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 9.38
$ 7.49 x 100
$ 11.36 x 100
-- - --
$ 8.46 - $ 10.44
23,084
na
293.13M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-16-2022 03-31-2022 10-Q
2 03-30-2022 12-31-2021 10-K
3 11-15-2021 09-30-2021 10-Q
4 08-16-2021 06-30-2021 10-Q
5 05-20-2021 03-31-2021 10-Q
6 03-31-2021 12-31-2020 10-K
7 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
06/09/2022 17:26:11

  On Thursday, 126 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
06/02/2022 17:27:44

  During the Thursday's session, 100 stocks hit new 52-week lows.

oaktree-acquisition-corp-ii-combination-partner-alvotech-highlights-avt04-clinical-study
Oaktree Acquisition Corp. II Combination P...
05/24/2022 11:10:23

The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara® (ustekinumab) met its primar...

alvotech-holdings-oaktree-acquisition-corp-ii-set-date-for-extraordinary-general-meeting-of-shareholders-to-approve-spac-deal-as-jun-7-2022
Alvotech Holdings, Oaktree Acquisition Cor...
05/11/2022 12:18:53

Alvotech Holdings S.A. (“Alvotech S.A.”), a global biopharmaceutical company focused solely on the development and manufacture ...

alvotech-holdings-sa-announces-resolution-of-europe-patent-dispute-with-abbvie
Alvotech Holdings S.A. Announces Resolutio...
04/06/2022 11:08:49

 Upon launch, HUKYNDRA® will be one of two citrate-free, high-concentration adalimumab biosimilars on the European market ...

benzingas-top-ratings-upgrades-downgrades-for-march-21-2022
Benzinga's Top Ratings Upgrades, Downgrade...
03/21/2022 14:09:30

Upgrades

northland-capital-markets-initiates-coverage-on-oaktree-acquisition-with-outperform-rating-announces-price-target-of-15
Northland Capital Markets Initiates Covera...
03/21/2022 13:28:37

Northland Capital Markets analyst Tim Chiang initiates coverage on Oaktree Acquisition (NYSE:OACB) with a Outperform rating ...

abbvie-alvotech-resolve-us-patent-dispute-related-to-humira-biosimilar
AbbVie, Alvotech Resolve US Patent Dispute...
03/09/2022 13:25:51

Alvotech Holdings S.A. has 

oaktree-acquisitions-merging-partner-alvotech-announces-fda-accepts-its-bla-supporting-interchangeability-for-atv02-a-high-concentration-citrate-free-biosimilar-candidate-for-humira
Oaktree Acquisition's Merging partner Alvo...
02/28/2022 12:12:02

Alvotech Holdings S.A. ("Alvotech"), a global biopharmaceutical company focused solely on the development and manufactu...

oaktree-acquisitions-merging-partner-alvotech-holdings-announces-co-enters-exclusive-global-licensing-agreement-with-biosanapharma-for-co-development-of-a-proposed-biosimilar-to-xolair
Oaktree Acquisition's Merging Partner, Alv...
02/02/2022 12:37:58

Alvotech Holdings S.A. ("Alvotech"), a global biopharmaceutical company focused solely on the development and manufactu...

oaktree-acquisition-corp-ii-spac-merger-partner-alvotech-highlights-upsizing-of-oversubscribed-pipe-transaction-to-175m
Oaktree Acquisition Corp. II SPAC Merger P...
01/18/2022 21:05:55

Alvotech Holdings S.A. (“Alvotech”), a leading global biopharmaceutical company focused solely on the development and manufactu...

oaktree-acquisition-corp-ii-spac-merger-partner-alvotech-reports-health-canada-granted-marketing-authorization-to-co-partner-jamp-pharma-for-a-high-concentration-biosimilar-to-humira
Oaktree Acquisition Corp. II SPAC Merger P...
01/10/2022 13:18:35

Health Canada rules that 40 mg/0.4 mL and 80 mg/0.8 mL presentations of SIMLANDI™ are not subject to the statutory stay, cleari...

biosimilar-player-alvotech-to-go-public-via-25b-oaktree-spac-merger
Biosimilar Player Alvotech To Go Public Vi...
12/08/2021 18:29:53

alvotech-and-oaktree-acquisition-corp-ii-announce-merger-agreement-combined-co-to-have-initial-enterprise-value-of-225b
Alvotech And Oaktree Acquisition Corp. II ...
12/07/2021 11:07:31

bloomberg-reported-alvotech-to-go-public-through-oaktree-spac-merger
Bloomberg Reported Alvotech to Go Public T...
12/07/2021 10:42:12

https://www.bloomberg.com/news/articles/2021-12-07/alvotech-is-said-to-be-going-public-through-oaktree-spac-merger

Core News & Articles
Stocks That Hit 52-Week Lows On Thursday
03/25/2021 15:01:47

    During Thursday's morning session, 92 stocks hit new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION